New York-based Varagon, a lender to middle market companies and private equity firms, has named Michael Broderick as a managing director of healthcare originations. Previously, he worked at Capital One where he originated debt, equity co-investments and banking opportunities for the firm’s private equity clients.
NEW YORK–(BUSINESS WIRE)–Varagon Capital Partners (“Varagon”) today announced that Michael Broderick has joined the firm as Managing Director of Healthcare Originations. In this role, he will be responsible for originating and structuring transactions for middle market private equity firms in the Healthcare sector. Previously, Mr. Broderick originated debt, equity co-investments and banking opportunities with Capital One’s private equity clients. Mr. Broderick will be based in New York and report to Steve Warden, Partner and Head of Healthcare at Varagon.
Mr. Warden commented, “We welcome Mike, along with his experience and strong relationships, to Varagon. We’ve made a significant investment in augmenting our Healthcare resources in 2018, and look forward to deploying these resources in conjunction with our private equity clients.”
Prior to Capital One, Mr. Broderick oversaw the healthcare sponsor finance team for CapitalSource. He began his career at GE Capital where he held various positions within the healthcare and sponsor finance teams. Mr. Broderick earned a B.A. degree from College of the Holy Cross and an M.B.A. from Northwestern’s Kellogg School of Management.
About Varagon Capital Partners
Varagon is a leading lender to middle market companies and private equity firms. Varagon invests across the capital structure and delivers flexible financing solutions that meet the needs of our private equity partners. Varagon provides investors with exposure to high-quality, directly-originated middle market loans through products designed for sophisticated institutions. Since inception, Varagon has made over $9.0 billion of investment commitments to over 120 middle market companies.
For additional information about Varagon, visit www.varagon.com.